Cellens was founded by Phuong (Jean) Pham in 2020.

Who are Cellens's investors?

Cellens's investors include IndieBio.

How much funding has Cellens raised?

Cellens has disclosed $7M raised across 2 rounds.

Where is Cellens headquartered?

Cellens is headquartered in Boston, US.

Cellens

Boston, US · Founded 2020 · Delaware corporation · 1 known investors

Find your way into Cellens

29 people in our graph share verified history with the Cellens team — schools, employers, funds. One of them is your warm intro.

Menno van der Zeeunlockedknows Phuong (Jean) Pham · together at Venture Development Center at UMass Boston (overlapped)

knows the team · via Cellens

knows the team · via Blue Startups

×9knows the team · via The College of Wooster

Cellens develops a non-invasive, urine-based cancer diagnostics platform (Octosense) that uses nanoscale atomic-force imaging of single-cell biophysical markers combined with machine learning to detect cancer, with early data focused on bladder cancer detection. It applies mechanobiology and label-free cell analysis to cancer screening.

AI & Machine Learning Biotech Healthtech Medical Devices

Founders & leadership

Cellens was founded in 2020 by Phuong (Jean) Pham.

Phuong (Jean) Pham inCo-Founder & CEOPhuong Pham is CEO of Cellens, which develops a non-invasive urine-based cancer diagnostics platform using nanoscale biophysical imaging and machine learning.

Phuong Nhu Pham inCo-Founder & CEO

Board

Deborah ZajacinBoard director

Lena Chaihorsky-HeringBoard director

Mohan Iyer in 𝕏Board directorGeneral Partner at SOSV

Jesse SalkinIndependent Board Director

Investors · 1

IndieBioreportedSan Francisco · $525K

Reported raises · per SEC filings

Form D private placements

$7M disclosed across 2 rounds · 2022–2025

▶$6.4MraisedNov 2025 · 33 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Deborah ZajacDirector
Lena Chaihorsky-HeringDirector
Mohan IyerDirector
Jesse SalkDirector
Phuong (Jean) PhamExecutive Officer, Director

Offering amount: $6.4M
Amount sold: $6.4M
Minimum investment: $747
First sale: Aug 2025
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$585KraisedOct 2022 · 15 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Phuong Nhu PhamExecutive Officer, Director

Offering amount: $1.5M
Amount sold: $585K
First sale: Apr 2022
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Linxens3 shared keywordsLinxens is a manufacturing and technology company operating across Europe, Asia, and the USA, with expertise in product design, engineering innovation, and R&D. The company serves multiple markets through manufacturing solutions and technology offerings.

Companies competing with Cellens for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Cellens Inc Secures $6,500,000 Seed Round Investment to Scale Operations | SignalBasetrysignalbase.com · Dec 2025

Cellens Raises $6.5M to Advance Its AI-Driven Mechanobiology Platform for Non-Invasive Bladder Cancer Diagnosticsnatlawreview.com

Frequently asked questions

What does Cellens do?: Cellens develops a non-invasive, urine-based cancer diagnostics platform (Octosense) that uses nanoscale atomic-force imaging of single-cell biophysical markers combined with machine learning to detect cancer, with early data focused on bladder cancer detection. It applies mechanobiology and label-free cell analysis to cancer screening.
Who founded Cellens?: Cellens was founded by Phuong (Jean) Pham in 2020.
Who are Cellens's investors?: Cellens's investors include IndieBio.
How much funding has Cellens raised?: Cellens has disclosed $7M raised across 2 rounds.
Where is Cellens headquartered?: Cellens is headquartered in Boston, US.